| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers Tenders > Headlines for 2021 > News item |
Grifols announces consent solicitation results for three series
Chicago, Aug. 9 – Grifols SA announced the results of its consent solicitation for three series of notes, according to a notice.
The company started a consent solicitation on July 30 for its €905 million 1 5/8% senior secured notes due 2025 (ISINs: XS2076836639, XS2076836555), the €770 million 2¼% senior secured notes due 2027 (ISINs: XS2077647365, XS2077646391) and the €1 billion 3.2% senior notes due 2025 (ISINs: XS1598758578, XS1598757760).
The consent solicitation was designed to allow an internal corporate reorganization and the issuance and sale of class B common stock in each of Biomat USA, Inc. and Biomat Newco Corp., indirect wholly owned subsidiaries of the company.
The solicitation was being undertaken in relation to an anticipated investment by an affiliate of GIC, the Singapore wealth fund, in Biomat USA.
Grifols needed consents from a majority of noteholders for the secured notes voting as a single class and a majority of noteholders of the unsecured notes by the 11 a.m. ET Aug. 6 deadline
Grifols received consents from holders of 87.93%, or €1,472,889,000, of the 1 5/8% notes and 2¼% notes together and from 81.01%, or €810.11 million, of its 3.2% notes.
The company received more than the consents it needed to adopt the proposed amendments.
Consenting noteholders will receive a consent payment of €2.50 per €1,000 note.
The solicitation agent was BofA Securities Europe SA (+33 1 877 01057, DG.LM_EMEA@bofa.com).
Lucid Issuer Services Ltd. was the tabulation and information agent (+44 20 7704 0880, grifols@lucid-is.com).
Grifols is a Sant Cugat del Valles, Barcelona-based health care company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.